BIOFILCHEM.NS
Key Ratios

Net Profit Margin: Making very low profit as compared to its revenue which generally means either business is inefficient or cost of making the product or services is higher than what it is finally worth

Acid Test Ratio: It has good liquidity, which means it can can cover its liabilities without relying on inventory

Inventory Turnover: Very High efficiency of inventory movement which means either good inventory management or under stocking risks

Coverage Analysis: At a very strong financial position where company is easily able to pay its interest payments from its earnings (EBIT + Lease Payments)

Debt to Equity Ratio: Company has low debt when compared to its equity which means it is financially stable

P/E Ratio: Overvalued stock which means company is making very less revenue per share but stock price is very high which represent speculative stock

Performance Graph
Financial Ratios
Ratio Value
PE Ratio130.77
Net Profit Margin0.02
Acid Test Ratio1.26
Inventory Turnover14.71
Coverage Ratio22.91
Debt to Equity0.02
Key Ratios

Net Profit Margin: Making very low profit as compared to its revenue which generally means either business is inefficient or cost of making the product or services is higher than what it is finally worth

Return on Assets: Very high efficiency of the assets which indicates assets are making high contribution to the revenue

Return on Equity: Very low income of the company when compared with its equity, which means inefficient equity

Performance Graph
Profitability Ratios
Ratio Value
Net Profit Margin0.02
Return on Assets1.04
Return on Equity0.04
Performance Graph
Key Ratios

Acid Test Ratio: It has good liquidity, which means it can can cover its liabilities without relying on inventory

Current Ratio: It has a good balance between assets & liabilities and would be just able to cover its short-term liabilities

Performance Graph
Liquidity Ratios
Ratio Value
Acid Test Ratio1.26
Current Ratio1.35
Performance Graph
Key Ratios

Inventory Turnover: Very High efficiency of inventory movement which means either good inventory management or under stocking risks

Performance Graph
Efficiency Ratios
Ratio Value
Inventory Turnover14.71
Performance Graph
Key Ratios

Coverage Analysis: At a very strong financial position where company is easily able to pay its interest payments from its earnings (EBIT + Lease Payments)

Performance Graph
Coverage Ratios
Ratio Value
Coverage Ratio22.91
Performance Graph
Key Ratios

Debt to Equity Ratio: Company has low debt when compared to its equity which means it is financially stable

Interest Coverage Ratio: Company is at low risk of getting default as it can easily cover its interest payments and strong financial health

Performance Graph
Solvency Ratios
Ratio Value
Debt to Equity Ratio0.02
Interest Coverage Ratio22.91
Performance Graph
Key Ratios

P/E Ratio: Overvalued stock which means company is making very less revenue per share but stock price is very high which represent speculative stock

Dividend Yield: NA

Performance Graph
Market Ratios
Ratio Value
P/E Ratio130.77
Gross Profit Margin0.06
Price to Book Ratio5.10
Dividend Yield0.00
Performance Graph

Balance Sheet Analysis of Biofil Chemicals and Pharmaceuticals Limited

The balance sheet in the financial statement of the company shows its financial position at a particular point in time.

It consists of the following:

  • Assets: Something that the company owns and that gives financial benefits over a period of time.
  • Liabilities: Something that a company owes and that has a financial burden on the company.
  • Equity: It is basically the owner’s share in the company.

The formula is:

Assets = Liabilities + Equity
đź“ŚAssets:
Asset
Value & Year
2024
2023
2022
Total Assets 470827000 314057000 187322000
Total Non Current Assets 86751000 90516000 94193000
Other Non Current Assets -1000 -1000 -1000
Non Current Prepaid Assets 509000 509000 -
Non Current Deferred Taxes Assets - - -
Financial Assets - - -
Investment In Financial Assets - - -
Held To Maturity Securities - - -
Available For Sale Securities - - -
Financial Assets Fair Value - - -
Long Term Equity Investment - - -
Investments In Associates At Cost - - -
Goodwill And Other Intangible Assets - - -
Other Intangible Assets - - -
Goodwill - - -
Net Ppe 86243000 90008000 94194000
Accumulated Depreciation -30262000 -26268000 -21977000
Gross Ppe 116505000 116276000 116171000
Construction In Progress - - -
Other Properties 2433000 2433000 2433000
Machinery Furniture Equipment 38997000 38989000 38979000
Buildings And Improvements 30116000 29895000 29800000
Land And Improvements 44959000 44959000 44959000
Properties - - -
Current Assets 384076000 223541000 93130000
Other Current Assets 264000 2369000 2478000
Hedging Assets Current - - -
Assets Held For Sale Current - - -
Restricted Cash - - -
Prepaid Assets 5189000 6003000 2480000
Inventory 25497000 12134000 12932000
Other Inventories -1000 -1000 -
Finished Goods 8031000 5306000 2258000
Work In Process - - 1035000
Raw Materials 17467000 6829000 9639000
Other Receivables - - -
Taxes Receivable - 2674000 2053000
Accounts Receivable 330291000 205027000 71737000
Allowance For Doubtful Accounts Receivable -1276000 -848000 -339000
Gross Accounts Receivable 331567000 205875000 72076000
Cash Cash Equivalents And Short Term Investments 22835000 377000 1450000
Other Short Term Investments 21909000 117000 600000
Cash And Cash Equivalents 22835000 377000 1450000
Cash Equivalents - - -
Cash Financial 22835000 377000 1450000
đź“Ś Liabilities & Equity
Liability/Equity
Value & Year
2024
2023
2022
Net Debt 3463000 4846000 3197000
Total Debt 4389000 5223000 4647000
Total Liabilities Net Minority Interest 288799000 141042000 18945000
Total Non Current Liabilities Net Minority Interest 3554000 3787000 3997000
Other Non Current Liabilities - - -1000
Derivative Product Liabilities - - -
Non Current Pension And Other Postretirement Benefit Plans - - -
Trade And Other Payables Non Current - - -
Non Current Deferred Revenue - - -
Non Current Deferred Taxes Liabilities 3554000 3787000 3998000
Long Term Debt And Capital Lease Obligation - - -
Long Term Capital Lease Obligation - - -
Long Term Debt - - -
Long Term Provisions - - -
Current Liabilities 285245000 137255000 14948000
Other Current Liabilities 1000 -30000 -1000
Current Deferred Taxes Liabilities 2400000 2300000 2710000
Current Debt And Capital Lease Obligation 4389000 5223000 4647000
Current Capital Lease Obligation - - -
Current Debt 4389000 5223000 4647000
Pension And Other Post Retirement Benefit Plans Current - - -
Current Provisions 2400000 2300000 2710000
Payables 277014000 129732000 7591000
Other Payable 1465000 3233000 1628000
Dividends Payable - - -
Total Tax Payable - - -
Accounts Payable 275549000 126499000 5963000
Common Stock Equity 182028000 173015000 168377000
Total Capitalization 182028000 173015000 168377000
Total Equity Gross Minority Interest 182028000 173015000 168377000
Minority Interest - - -
Stockholders Equity 182028000 173015000 168377000
Other Equity Interest 19290000 10277000 5639000
Treasury Stock - - -
Retained Earnings -316944000 -325957000 -330595000
Additional Paid In Capital 83331000 83331000 83331000
Capital Stock 162738000 162738000 162738000
Common Stock 162738000 162738000 162738000

Income statement interpretation for Biofil Chemicals and Pharmaceuticals Limited

The income statement in the financial statement of the company shows its company financial performance over a period in time.

It consists of the following:

  • Revenue: It is the total amount of money earned from the core business activity of the company.
  • Expenses: It is the total amount required for running the full functionality of the company.
  • Profit or loss:In very simple terms, when a company pays its expenses using its revenue, then what’s left is profit, and in case expenses are more when compared with revenue, then it is loss.
đź“ŚRevenue & Profitability
Revenue/Profitability
Value & Year
2024
2023
2022
Total Revenue 400353000 300352000 223823000
Operating Revenue 400353000 300352000 223823000
Cost Of Revenue 375075000 274233000 194604000
Gross Profit 25278000 26119000 29219000
Ebitda 13042000 12640000 14915000
Ebit 9048000 8349000 10539000
Operating Income 4171000 7386000 9050000
Net Income 7092000 5604000 6984000
Net Income From Continuing Operation Net Minority Interest 7092000 5604000 6984000
Net Income From Continuing And Discontinued Operation 7092000 5604000 6984000
Net Income Common Stockholders 7092000 5604000 6984000
Net Income Including Noncontrolling Interests 7092000 5604000 6984000
Net Income Discontinuous Operations - - -
Net Income Continuous Operations 7092000 5604000 6984000
Normalized Income 7092000 5604000 6984000
Normalized Ebitda 13042000 12640000 14915000
Total Unusual Items - - -
Total Unusual Items Excluding Goodwill - - -
đź“ŚExpenses & Taxes
Expenses/Taxes
Value & Year
2024
2023
2022
Reconciled Depreciation 3994000 4291000 4376000
Reconciled Cost Of Revenue 375075000 274233000 194604000
Total Expenses 396182000 292966000 214773000
Operating Expense 21107000 18733000 20169000
Other Operating Expenses 8885000 6663000 5784000
Depreciation And Amortization In Income Statement 3994000 4291000 4275000
Amortization - - -
Depreciation Income Statement 3994000 4291000 4275000
Selling General And Administration 1517000 1525000 1953000
Selling And Marketing Expense 116000 162000 74000
General And Administrative Expense 1401000 1363000 1879000
Rent And Landing Fees - - -
Tax Provision 1561000 2326000 3165000
Pretax Income 8653000 7930000 10149000
Other Non Operating Income Expenses 4830000 954000 1293000
Special Income Charges - - -
Other Special Charges - - -
Write Off - - -
Net Non Operating Interest Income Expense -348000 -409000 -196000
Total Other Finance Cost 20000 6000 16000
Interest Expense Non Operating 395000 419000 390000
Interest Income Non Operating 67000 16000 210000
đź“Ś Earnings Per Share
Earnings Per Share
Value & Year
2024
2023
2022
Diluted Eps 0.44 0.34 0.44
Basic Eps 0.44 0.34 0.44
Diluted Ni Avail To Com Stockholders 7092000 5604000 6984000
Net Income From Continuing Operations 8653000 7930000 10149000
Minority Interests - - -

Cash flow analysis for Biofil Chemicals and Pharmaceuticals Limited

The cashflow statement in the financial statement of the company shows how cash is moving in or moving out of the company over a period of time.

It consists of the following:

  • Operating activities: Cash flow from the core business operations.
  • Investing activities: Cashflow from investments made by the company.
  • Financing activities: These are cash from loans or by issuing shares or paying out dividends.
đź“ŚOperating Cash Flow
Operating Cash Flow
Value & Year
2024
2023
2022
Operating Cash Flow 23937000 -1118000 -2199000
Changes In Cash 22459000 -1073000 -2956000
Taxes Refund Paid -1561000 -2326000 -3165000
Change In Working Capital 10515000 -10473000 -13966000
Change In Other Current Liabilities -459000 984000 61000
Change In Other Current Assets 551000 500000 7574000
Change In Payable 149050000 120536000 -152557000
Change In Inventory -13363000 797000 30514000
Change In Receivables -125264000 -133290000 100442000
Other Non Cash Items 415000 425000 406000
Stock Based Compensation - - -
Provision And Write Off Of Assets - - -
Depreciation And Amortization 3994000 4291000 4376000
Amortization Cash Flow - - -
Depreciation 3994000 4291000 4376000
đź“ŚInvesting Cash Flow
Investing Cash Flow
Value & Year
2024
2023
2022
Investing Cash Flow -229000 -106000 -699000
Net Other Investing Changes - - -
Interest Received Cfi - - -
Dividends Received Cfi - - -
Net Investment Purchase And Sale - - -
Sale Of Investment - - -
Purchase Of Investment - - -
Net Business Purchase And Sale - - -
Sale Of Business - - -
Purchase Of Business - - -
Net Ppe Purchase And Sale -229000 -106000 -699000
Sale Of Ppe - - -
Purchase Of Ppe -229000 -106000 -699000
Net Intangibles Purchase And Sale - - -
Purchase Of Intangibles - - -
đź“Ś Financing Cash Flow
Financing Cash Flow
Value & Year
2024
2023
2022
Financing Cash Flow -1249000 151000 -58000
Net Other Financing Charges 82566000 - -
Interest Paid Cff -415000 -425000 -406000
Cash Dividends Paid - - -
Common Stock Dividend Paid - - -
Net Common Stock Issuance - - -
Common Stock Payments - - -
Common Stock Issuance - - -
Repurchase Of Capital Stock - - -
Repayment Of Debt - - -
Issuance Of Debt - - -
Issuance Of Capital Stock - - -
Net Issuance Payments Of Debt -83400000 576000 348000
Net Short Term Debt Issuance - 576000 348000
Short Term Debt Issuance - - -
Net Long Term Debt Issuance -83400000 576000 348000
Long Term Debt Payments - - -
Long Term Debt Issuance - - -
Net Preferred Stock Issuance - - -
Preferred Stock Payments - - -

Summary

Fundamental Overview of BIOFILCHEM.NS (Biofil Chemicals and Pharmaceuticals Limited)

Above is the summary for fundamental analysis of Biofil Chemicals and Pharmaceuticals Limited , whose ticker name is BIOFILCHEM.NS and belongs to sector Healthcare, and it is listed in NSE (National Stock Exchange).

The Biofil Chemicals and Pharmaceuticals Limited which is listed in NSE (National Stock Exchange) has a PE ratio of 130.77, BIOFILCHEM.NS has a net profit margin of 0.02, the acid test ratio for BIOFILCHEM.NS is 1.26, BIOFILCHEM.NS has an inventory turnover of 14.71, and BIOFILCHEM.NS has debt-to-equity ratio of 0.02.

The BIOFILCHEM.NS whose company name is Biofil Chemicals and Pharmaceuticals Limited has made profit/loss of 25278000 with total revenue of 400353000, BIOFILCHEM.NS has assets worth of 470827000.

1. What is fundamental analysis?

Fundamental analysis is looking into a company’s real business performance by analyzing financial statements, earning reports, and key valuation ratios.

Basically, fundamental analysis involves examining a company’s revenue, profits, losses, debts, assets, liabilities, and ratios calculated using these values to determine long-term investment strategies.

Fundamental analysis may not work for short-term trading of stock; it is usually incorporated by long-term investors.

2. Importance of Fundamental Analysis

Imagine you are locking a good amount of funds into an unknown company for many years. Sounds stupid, right?

This is where fundamental analysis comes into the picture, which turns an unknown enemy into a known friend.

As fundamental analysis involves calculating how a company is actually performing, the real revenue, profits, assets, liabilities, debts, and more. This helps investors to determine what the actual current financial condition of the company is, how much the company’s stock price is justified when compared to earnings (Corporate earnings reports India) that it is making through business, what the probability is that the company will go bankrupt in the future, how much growth the company has shown in the past, and other financial ratios.

All these calculations and analyses determine the financial health of the company, historical business growth, company’s efficiency, and its stock price compared with real earnings (Corporate earnings reports India), which helps traders to make investment decisions for long-term investment strategies.

2. How to Use Our Tool

  • Search for the stock that you want to analyze in the search bar by typing the name of the company or ticker.
  • Once you land on the Stock Analytics Page, click on “Fundamental Analysis”; this will take you to the fundamental analysis page.
  • Apply Filter
  • On the “Fundamental Analysis” page, the first tab is for “Summary and Ratio,” where in the top section you can find the overall summary of the stock’s fundamental analysis, where on the leftmost side it has a textual summary, then in the middle a gauge chart that represents overall financial health, and then a list of important ratios.
  • Apply Filter
  • Then in the same “Summary and Ratio” tab, we have included a detailed analysis of stock in various aspects, which includes “Profitability Analysis,” “Liquidity Analysis,” “Efficiency Analysis,” “Coverage Analysis,” Solvency Analysis,” and “Market Analysis,” which divide the stock’s fundamentals into the above aspects and analyze each in the same format as for overall analysis, where the leftmost side has a textual summary, then in the middle a gauge chart that represents overall analysis of the particular section, and then a list of important ratios. Required for the particular analysis.
  • Apply Filter